|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Factors that impact symptomatic diabetic peripheral neu- ropathy in placebo-administered patients from two 1 -year clinical trials 显示文摘 | Tesfaye S Tandan R Bastyr E J | 2007 | Diabetes Care2007，30，10： | 1 |
| 2 | Therapy focused on lowering postprandial glucose, not fasting glucose, may be superior for lowering HbAic显示文摘 | Bastyr EJm Stuart CA Brodows RG | 2000 | Diabetes Care2000，23，： | 1 |
| 3 | Therapy focused on lowering postprandial glucose, not fasting glucose, may be superior for lowering HbAlc显示文摘 | Bastyr E J Stuart CA Brodows RG | 2000 | Diabetes Care2000，23，： | 1 |
| 4 | Therapy focused on lowering postprandial glucose,not fasting glucose,may be superior for lowering HbA1c:IOEZ Study Group显示文摘 | Bastyr EJ 3rd Stuart CA Brodows RG | | 0，，： | 1 |
| 5 | Development and validity testing of the neuropathy total symptom score-6: qestionnaire for the study of sensory symptoms of diabetic peripheral neuropathy 显示文摘 | Bastyr E J Price KL Bril V | 2005 | Clin Ther2005，27，8： | 1 |
| 6 | Factors that impact symptomatic diabetic peripheral neuropathy in placebo-administered patients from two 1-year clinical trials显示文摘 | Tesfaye S Tandan R Bastyr EJ | 2007 | Diabetes Care2007，30，10： | 1 |
| 7 | Develop- ment and validity testing of the neuropathy total symptom score-6: questionnaire for the study of sensory symptoms of diabetic peripheral neuropathy显示文摘 | BASTYR EJ 3RD PRICE KL BRIL V | 2005 | Clinical Therapeu- tics2005，27，8： | 1 |
| 8 | Development andvalidity testing of the neuropathy total symptom score-6:questionnaire for the study of sensory symptoms of dia-betic peripheral neuropathy 显示文摘 | BASTYR ER PRICE KL BRIL V | 2005 | Clin Ther2005，27，8： | 1 |
| 9 | Factors that impact symptomatic diabetic peripheral neuropathy in placebo - administered patients from two 1 - year clinical trials 显示文摘 | Tesfaye S Tandan R Bastyr EJ 3rd | 2007 | Diabetes Care2007，30，10： | 1 |
| 10 | Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C β-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial显示文摘 | Aaron I. Vinik Vera Bril Peter Kempler William J. Litchy Solomon Tesfaye Karen L. Price Edward J. Bastyr | 2005 | Clinical Therapeutics2005，，8： | 1 |
| 11 | Development and validity testing of the nenropathy total symptom score-6: questionnaire for the study of sensory symptoms of diabetic peripheral neu- ropathy显示文摘 | BASTYR ER PRICE KL BRIL V | 2005 | Clin Ther2005，27，8： | 1 |
| 12 | Factors that impact symptomatic diabetic per/pheral neuropathy in place- bo-administered patients from two 1-year clinical trials显示文摘 | TESFAYE S TANDAN R BASTYR ER | 2007 | Dia- betes Care2007，30，10： | 1 |
| 13 | Therapy focused on lowering postprandial glucose,not fasting glucose,may be superior for lowering HbA1c:IOEZ Study Group显示文摘 | Bastyr EJ 3rd Stuart CA Brodows RG Schwartz S Graf CJ Zagar A Robertson KE | 2000 | Diabetes Care2000，23，9： | 1 |
| 14 | On the acoustic radiation from a loudspeaker's cabinet显示文摘 | BASTYR K J CAPONE D E | 2001 | Journal of Audio Engineering Society2001，51，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员